Xcout IntelPasithea Therapeutics Corp. competitors & alternatives
The 12 closest competitors and alternatives to Pasithea Therapeutics Corp. among biotech companies — ranked by similarity to what Pasithea Therapeutics Corp. actually does, not by market-cap band.
Subscribe to see Pasithea Therapeutics Corp.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Pasithea Therapeutics Corp.
Pasithea Therapeutics Corp. functions as a biotechnology firm dedicated to the discovery and advancement of novel therapeutic solutions for various psychiatric and neurological conditions. Beyond its research endeavors, the company also plans to establish and manage clinics specializing in depression treatment. These facilities are designed to offer business support, employing trained pharmacists to administer intravenous ketamine infusions. Founded in 2020, the corporation's primary operations are based in Miami Beach, Florida.
Pasithea Therapeutics Corp. at a glance
Pasithea Therapeutics Corp. is a biotech company headquartered in Miami Beach, United States. It is publicly listed (KTTA) with a market capitalisation of $14.7M. Xcout tracks 10 named people at Pasithea Therapeutics Corp., including Tiago Reis Marques (Chief Executive Officer & Director).
Pasithea Therapeutics Corp. leadership
- Tiago Reis MarquesChief Executive Officer & Director
- Daniel H. SchneidermanChief Financial Officer
- Kartik KrishnanChief Medical Officer
- Lawrence SteinmanCo-Founder & Executive Chairman
- Alfred J NovakDirector
- David DelaneyDirector
4 more named people on record for Pasithea Therapeutics Corp., with roles, board committees and tenure — see the full roster →
Top 12 Pasithea Therapeutics Corp. competitors
Ranked by semantic similarity — how close each company is to Pasithea Therapeutics Corp. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Biotechnology
Gilgamesh Pharma Inc. is a clinical-stage neuroscience company that develops novel chemical entities to treat psychiatric diseases, aiming to move beyond symptom management toward rapid-acting and durable therapies. The company utilizes an AI-powered discovery platform and medicinal chemistry to create precision therapies targeting conditions such as depression, anxiety, addiction, and schizophrenia.
Biotechnology
AtaiBeckley Inc. has its corporate headquarters located in New York, USA. The biopharmaceutical company is on a mission to transform patient outcomes by developing effective, rapid-acting, and convenient mental health treatments.
Similar biotech company
Beckley Psytech is a UK-based clinical-stage biotechnology company developing psychedelic medicines for psychiatric and neurological disorders. Its programs have included BPL-003, an intranasal formulation of 5-MeO-DMT, intended for conditions such as treatment-resistant depression and alcohol use disorder.
Biotechnology
Lykos Therapeutics is a biotechnology company developing psychedelic-assisted therapies, particularly MDMA-assisted therapy for post-traumatic stress disorder (PTSD). It works with clinicians and researchers to advance regulated treatments for people with PTSD and related mental-health conditions.
Similar biotech company
ATAI Life Sciences AG is a biopharmaceutical company headquartered in Munich, Germany, focused on acquiring and developing innovative treatments for mental health disorders.
Similar biotech company
Elkedonia is a biotechnology company committed to introducing a pioneering, first-in-class antidepressant treatment utilizing precision medicine. Headquartered in Strasbourg, France, the company brings together stakeholders across the European ecosystem to advance innovative therapeutics.
Biotechnology
Reunion Neuroscience is a clinical-stage biopharmaceutical company that develops innovative therapeutics for underserved mental health disorders. Its lead drug candidate, luvesilocin, is a proprietary 5-HT2A agonist designed to provide durable antidepressant effects for patients with mood and anxiety disorders.
Biotechnology
COMPASS Pathways plc is a mental healthcare company with a primary presence in the United Kingdom and the United States. Established in 2020 and headquartered in London, UK, the firm focuses on developing novel treatments. Its key product is COMP360, an investigational psilocybin therapy. This therapy has advanced through Phase IIb clinical trials for treatment-resistant depression and is currently undergoing Phase II trials for post-traumatic stress disorder. The company previously operated under the name COMPASS Rx Limited before rebranding to COMPASS Pathways plc in August 2020.
Similar biotech company
Synendos Therapeutics is a clinical-stage biopharmaceutical and neuroscience company focused on developing a novel class of small molecules to treat psychiatric and neurological disorders.
Life Sciences (Therapeutics)
Eumentis Therapeutics, Inc. is a clinical-stage biopharmaceutical company headquartered in San Diego, California, dedicated to developing novel therapies for serious neuropsychiatric conditions.
Biotechnology
Intra-Cellular Therapies was a U.S. biopharmaceutical company focused on developing treatments for central nervous system disorders. Its principal product, CAPLYTA (lumateperone), is used to treat schizophrenia and depressive episodes associated with bipolar disorder in adults, serving patients and mental-healthcare providers.
Biotechnology
Serenatis Bio is a biotechnology company founded in 2024 and headquartered in Cambridge, United Kingdom. It is developing novel, precision therapeutics for obsessive-compulsive disorder (OCD).
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Pasithea Therapeutics Corp. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Pasithea Therapeutics Corp.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →